Highlighted transactions

Healthcare

 

Voyager Therapeutics, Inc.

Piper Jaffray served as joint bookrunner on the $70 million IPO for Voyager Therapeutics, Inc.

Client Description

Voyager Therapeutics is a clinical-stage gene therapy company focused on developing lifechanging treatments for patients suffering from severe diseases of the central nervous system, or CNS.

Back